Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group

Detalles Bibliográficos
Autores principales: Damaschin, Carla, Goergen, Helen, Kreissl, Stefanie, Plütschow, Annette, Breywisch, Frank, Mathas, Stephan, Meissner, Julia, Sökler, Martin, Topp, Max S., Vucinic, Vladan, Zimmermann, Andreas, von Tresckow, Bastian, Fuchs, Michael, Engert, Andreas, Borchmann, Peter, Eichenauer, Dennis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807388/
https://www.ncbi.nlm.nih.gov/pubmed/34408266
http://dx.doi.org/10.1038/s41375-021-01386-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807388/
https://www.ncbi.nlm.nih.gov/pubmed/34408266
http://dx.doi.org/10.1038/s41375-021-01386-z

Ejemplares similares